Bachem Shares Jump on CHF 500 Million Investment in New Facility

Shares of Bachem (SIX:BANB) jumped 7.8% after the Swiss peptide manufacturer announced an investment exceeding 500 million Swiss francs ($617.7 million) in a new greenfield project at its Sisslerfeld site. The major capital expenditure is part of a strategic collaboration with an undisclosed partner.

Sisslerfeld Expansion Details

The investment is aimed at significantly expanding Bachem's production capabilities. While the company did not name its partner, it confirmed the project is supported by a long-term agreement with a customer, providing a foundational contract for the new facility's development.

Greenfield projects, which involve building entirely new facilities, represent substantial capital commitments and typically signal a company's confidence in sustained future demand.

Ad

Analyst View and Market Impact

Investors reacted positively to the strategic move, driving the company's shares higher. Analysts at Vontobel described the secured long-term customer agreement as a positive development for Bachem, according to a note from the brokerage.

Vontobel also highlighted that the financial risk to Bachem is mitigated because the company will not have to bear the entire financial burden of the project. The firm cautioned, however, that additional customer contracts will likely be needed to advance the site's development further.